EP3495380
Glúkagon og GLP-1 sam-örvar til meðhöndlunar á offitu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.12.2013EP published:
30.3.2022EP application number:
18182274.3
EP translation filed:
9.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
9.12.2033Expiry date:
9.12.2025Next due date:
31.12.2025
Title in English:
GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITYLanguage of the patent:
English
Timeline
Today
10.12.2013EP application
30.3.2022EP Publication
9.6.2022Translation submitted
15.7.2022Registration published
9.12.2025Expires
Owner
Name:
MedImmune LimitedAddress:
Milstein Building Granta Park, Cambridge Cambridgeshire CB21 6GH, GB
Inventor
Name:
AGORAM, BalajiAddress:
Cambridge, CB21 6GH, GB
Name:
ANTONSSON, MadeleineAddress:
SE-151 85 Södertälje, SE
Name:
BEDNAREK, Maria, AAddress:
Cambridge, Cambridgeshire CB21 6GH, GB
Name:
BURMEISTER, NicoleAddress:
Cambridge, CB21 6GH, GB
Name:
BENTHEM, LambertusAddress:
SE-151 85 Södertälje, SE
Name:
FAIRMAN, DavidAddress:
Cambridge, CB21 6GH, GB
Name:
FRITSCH-FREDIN, MariaAddress:
SE-151 85 Södertälje, SE
Name:
JACKSON, Ronald HenryAddress:
Cambridge, CB21 6GH, GB
Name:
LOFMARK, Rasmus JanssonAddress:
SE-151 85 Södertälje, SE
Name:
METCALFE, JaquelineAddress:
Cambridge, CB21 6GH, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261735823 PDate:
11.12.2012Country:
US
Classification
Categories:
A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 15.12.2022
Expires: 9.12.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 15.11.2023
Expires: 9.12.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.11.2024
Expires: 9.12.2025
Payer: Árnason Faktor ehf.